Last reviewed · How we verify
oxyhydrogen nanobubble infusion
At a glance
| Generic name | oxyhydrogen nanobubble infusion |
|---|---|
| Sponsor | dr. Siti Nurlaela, SpN |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |